AFLIBERCEPT for Choroidal neovascularisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 2,953 adverse event reports in the FDA FAERS database where AFLIBERCEPT was used for Choroidal neovascularisation.

Most Reported Side Effects for AFLIBERCEPT

Side Effect	Reports	%	Deaths	Hosp.
Death	7,669	28.5%	7,666	73
Visual impairment	1,836	6.8%	14	167
Blindness	1,337	5.0%	7	134
Endophthalmitis	1,289	4.8%	5	203
Off label use	1,156	4.3%	115	140
Eye pain	1,057	3.9%	5	120
Product dose omission issue	1,051	3.9%	4	40
Blindness unilateral	1,012	3.8%	11	88
Vision blurred	1,012	3.8%	10	97
Visual acuity reduced	993	3.7%	8	89
Blindness transient	987	3.7%	3	30
Drug ineffective	961	3.6%	18	56
Eye inflammation	875	3.3%	4	44
Eye haemorrhage	739	2.8%	2	50
Intraocular pressure increased	690	2.6%	2	33